A group of scientists from Israel have released the exciting news that their research is closing in and they will find a cure for cancer next year.
With 18 million new cancer cases cropping up every year, scientists are getting closer and closer to discovering a cure for the disease. A new group of scientists from Israel claims they are closer than ever before.
Dan Aridor, the CEO of Accelerated Evolution Biotechnologies, told the Jerusalem Post, “We believe we will offer in a year’s time a complete cure for cancer. It will be effective from day one, will last a duration of a few weeks. It will have no or minimal side-effects at a much lower cost than most other treatments on the market.
The treatment is called MuTaTo (Multi-Target Toxin). It is a combination of cancer-targeting peptides and cancer-killing toxins, making it like an antibiotic for cancer. The company has used at least three peptides on the same structure with a strong toxin, saying it “made sure that the treatment will not be affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by cancer.”
According to the company, the treatment can also eventually be personalized. A specific mixture of both the peptides and toxins can be created depending on the patient’s cancer. Ideally, the company hopes that they will be able to stop treatment after several weeks and not require a lifetime of drugs. Morad has equated this with the AIDS medication that took the disease from being life-threatening to chronic but manageable.
The CEO said that the treatment has only been tested on mice. It has shown success, with human cancer cell growth being inhibited and healthy mice cells remaining unaffected. It is now nearing the stage of clinical trial.
A representative of the American Cancer Society said, “This is far from proven as an effective treatment for people with cancer, let alone a cure. The news report is based on limited information provided by researchers and this work apparently has not been published in scientific literature.”
Dr. Len Lichtenfeld of the American Cancer Society wrote in a blog, “It goes without saying, we all share the aspirational hope that they are correct. Unfortunately, we must be aware that this is far from proven as an effective treatment for people with cancer, let alone a cure.”
“If this group is just beginning clinical trials, they may well have some difficult experiments ahead,” he added.
He also said, “It is certainly possible this approach may be work. However, as experience has taught us so many times, the gap from a successful mouse experiment to effective, beneficial application of exciting laboratory concepts to helping cancer patients at the bedside is, in fact, a long and treacherous journey, filled with unforeseen and unanticipated obstacles.”
Dr. Ben Neel of the Perlmutter Cancer Center at NYU told The Post that “cancer is multiple diseases, and it is highly unlikely that this company has found a ‘cure’ for cancer any more than there is a single cure for infections.” He added that it was “more likely, this claim is yet another in a long line of spurious, irresponsible and ultimately cruel false promises for cancer patients.”
There is no overall cure for cancer currently. So, it is in remission at best.